Toxicity and Early Biochemical Outcomes From 125Iodine Prostate Brachytherapy in the U.K.: A Prospective Study
- 30 April 2004
- journal article
- Published by Elsevier in Clinical Oncology
- Vol. 16 (2) , 95-104
- https://doi.org/10.1016/j.clon.2003.11.006
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Monotherapy for stage T1/T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent prostate brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2002
- (125)Iodine prostate brachytherapy: outcome from the first 100 consecutive patients and selection strategies incorporating urodynamics.BJU International, 2002
- Radical prostatectomy in Britain and Ireland at the millenniumBJU International, 2002
- Prostate brachytherapy has come of age: a review of the technique and resultsBJU International, 2002
- 10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Modern prostate brachytherapyCancer, 2000
- Palladium-103 brachytherapy for prostate carcinomaPublished by Elsevier ,2000
- Patient-reported urinary continence and sexual function after anatomic radical prostatectomyUrology, 2000
- Short‐term morbidity and acceptability of 125iodine implantation for localized carcinoma of the prostateBJU International, 1999
- Prevalence and impact of incontinence and impotence following total prostatectomy assessed anonymously by the ICS-male questionnaire.European Urology, 1998